Why Merrill went with Thain instead of Fink


CNBC's Charlie Gasparino reported that Laurence Fink, who was offered the Merrill Lynch (NYSE: MER) CEO job, asked Merrill's board for a complete accounting of the subprime problem there before he would agree to accept the position. This request encouraged Merrill's board to "go in a different direction."

If Fink did not like the results of the subprime audit, he could have turned down the position and left Merrill's board in the awkward situation of needing to disclose the truth of the situation. What I find amazing is that Merrill's board needed Fink to drag it into making such an audit. And then it decided that it would rather offer the CEO job to someone else who wouldn't force it to come to grips with its problems.

John Thain is going to have a tough job ahead of him. But Merrill's gain is Citigroup Inc.'s (NYSE: C) loss.

Peter Cohan is President of Peter S. Cohan & Associates. He also teaches management at Babson College and edits The Cohan Letter. He owns Citigroup stock and has no financial interest in Merrill Lynch.

Reader Comments (Page 1 of 1)

Symbol Lookup
IndexesChangePrice
DJIA-33.4512,598.55
NASDAQ-19.722,874.04
S&P 500-5.861,324.80

Last updated: May 16, 2012: 05:59 PM

Hot Stocks

General Electric

19.00+0.60(+3.26)

Alcoa

8.49-0.22(-2.53)

Apple Inc

546.075-7.095(-1.28)

Google Inc 'A'

628.93+17.82(+2.92)

Bank of America

7.11-0.19(-2.60)

Wal-Mart Stores

59.19-0.16(-0.27)

Exxon Mobil Corp

82.17+0.38(+0.46)

Ford

10.16+0.01(+0.10)

Citigroup

26.92-0.87(-3.13)

IBM

199.73+0.69(+0.35)

Yahoo

15.28-0.12(-0.78)

Starbucks

53.02-0.32(-0.60)

Microsoft

29.90-0.31(-1.03)

Home Depot

48.77+0.10(+0.21)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1337205566036 ms.